**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 60-11-7 |4-Dimethylaminoazobenzene | 100 | 200-455-7 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 25 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic if swallowed. Limited evidence of a carcinogenic effect.Cancer
suspect agent.
Potential Health Effects
Eye:
Contact with eyes may cause severe irritation, and possible eye
burns.
Skin:
May cause severe skin irritation. May cause dermatitis. May be
harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause digestive tract disturbances. May
form methemoglobin which in sufficient concentration causes cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood).
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. If breathing has ceased
apply artificial respiration using oxygen and a suitable mechanical
device such as a bag and a mask. Do not use mouth-to-mouth
resuscitation if victim ingested or inhaled the substance; induce
artificial respiration with the aid of a pocket mask equipped with a
one-way valve or other proper respiratory medical device.
Notes to Physician:
Effects may be delayed. Treat symptomatically and supportively. For
methemoglobinemia, administer oxygen alone or with Methylene Blue
depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Decomposes at high temperatures, resulting in toxic
and corrosive products. Containers may explode when heated.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
Cool containers with flooding quantities of water until well after
fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Avoid generating dusty conditions. Provide
ventilation. Vacuum or sweep up material and place into a suitable,
dry disposal container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Do not
get in eyes, on skin, or on clothing. Keep container tightly closed.
Do not breathe dust. Use only with adequate ventilation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Poison room locked. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits. See 29CFR 1910.1003 for specific
regulatory requirements applying to areas containing a listed
carcinogen, signs, training, reports, and medical surveillance
programs.
Exposure Limits
CAS# 60-11-7:
United States OSHA: ; (Cancer suspect agent - see 29 CFR 1910.101
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: orange-brown - orange
Odor: None reported.
pH: ca. 5-7 (10g/l aq soln.)
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 111-117 deg C (dec)
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 111-117 deg C
Solubility in water: 13.6mg/l in water
Specific Gravity/Density:
Molecular Formula: C14H15N3
Molecular Weight: 225.29
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Acids - acid anhydrides - oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 60-11-7: BX7350000
LD50/LC50:
CAS# 60-11-7: Oral, mouse: LD50 = 300 mg/kg; Oral, rat: LD50 = 200
mg/kg.
Carcinogenicity:
4-Dimethylaminoazobenzene -
California: carcinogen, initial date 1/1/88
NTP: Suspect carcinogen
IARC: Group 2B carcinogen
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: DYE, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3143
Packing Group: III
IMO
Shipping Name: DYE, SOLID, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3143
Packing Group: III
RID/ADR
Shipping Name: DYE, SOLID, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3143
Packing group: II
USA RQ: CAS# 60-11-7: 10 lb final RQ; 4.54 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 25 Toxic if swallowed.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 60-11-7: No information available.
Canada
CAS# 60-11-7 is listed on Canada's DSL List.
CAS# 60-11-7 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 60-11-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/03/1998 Revision #3 Date: 12/18/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Vinyl Acetate
| 108-05-4 |
|
Dichlorophenylphosphine, 97%
| 644-97-3 |
|
5-Nitro-2-N-(Propylamino)Pyridine
| 25948-11-2 |
|
Ethyl cellulose, Ethoxyl Content 48%, 4 CPS
| 9004-57-3 |
|
Crotyl alcohol, 90% (gc)
| 6117-91-5 |
|
Lead(ii) methanethiolate, 99% (titr.)
| 35029-96-0 |
|
3-exo-Hydroxymethylbicyclo[2.2.1]heptyl-2-exo-amine hydrochloride,
| |
|
4,4'-Sulfonyldiphenol, 99.7% (HPLC)
| 80-09-1 |
|
(Diphenylthiocarbazono)phenylmercury
| 56724-82-4 |
|
3-Iodotoluene, 99%
| 625-95-6 |
|
1(2-Methoxyphenyl)piperazine hydrochloride, 99%(tlc)
| 5464-78-8 |
|
3,3-Dimethyl-1-Butene, 95%
| 558-37-2 |
|
Benzyltriethylammonium chloride, 98%
| 56-37-1 |
|
1-Cyclohexene-1-carboxylic acid, 96% (GC)
| 636-82-8 |
|
4-Bromo-2-Fluorobenzonitrile, 99+%
| 105942-08-3 |
|
Eicosanoic acid, 99%
| 506-30-9 |
|
2,3-Dichlorotoluene, 98%
| 32768-54-0 |
|
3-Methoxy-1-butanol, 99%
| 2517-43-3 |
|
Germanium Tetrachloride, 99.99%
| 10038-98-9 |
|
2-Naphthaldehyde, 98%
| 66-99-9 |
|
1-Pentanesulfonic acid sodium salt premixed concentrate (Low UV)
| 67-56-1 |
|
Cis-1,2-Cyclohexanedimethanol, 98%
| 15753-50-1 |
|
Tetrabutylammonium Bromide,99% (titr.)
| 1643-19-2 |
|
N,N'-Bis(Phenylmethylene)-1,2-Ethylenediamine, 99.5+%
| 0-01-1 |
|
Wood's Metal
| 7439-92-1 |
|
N,N-Diethyldodecanamide, 98+%
| 3352-87-2 |
|
Thiocarbanilide, 98%
| 102-08-9 |
|
2-Hydroxy-5-nitropyridine, 99+%
| 5418-51-9 |
|
Xylenes, mixed isomers with ethylbenzene (Flash Point 26.1C / 79F;
| 100-41-4 |
|
Xylenol Orange Tetrasodium Salt
| 3618-43-7 |
|
Nile Red, 99% (UV-VIS)
| 7385-67-3 |
|
1-Aminoindan, 99%
| 34698-41-4 |
|
4-Fluorobenzyl Alcohol, 98%
| 459-56-3 |
|
Brilliant Sulphaflavine
| 2391-30-2 |
|
4,4'-Diaminostilbene-2,2'-Disulfonic Acid, 95% (UV-Vis)
| 81-11-8 |
|
n-Methylacetoacetamide, 70 wt % aqueous solution
| 7732-18-5 |
|
Zinc Metal Powder
| 7440-66-6 |
|
cis-1,2-Cyclohexanedicarboxylic anhydride, 99%
| 13149-00-3 |
|
5-Methoxy-2-Methylbenzothiazole
| 2941-69-7 |
|
Zinc acetate dihydrate
| 557-34-6 |
|
Methyl Yellow, indicator grade
| 60-11-7 |
|
Aristolochic acid, mixture of I and II (approx. 1:1)
| 313-67-7 |
|
Ethyl 5-bromo-2-chlorobenzoate, 97%
| 76008-73-6 |
|
Butyl stearate, mixture of ca. 55-65% stearyl- and 25-40% cetyl-
| 111-06-8 |
|
Zinc bromide
| 7699-45-8 |
|
Zinc Carbonate
| 3486-35-9 |
|
(r)-(-)-2-Amino-3-methyl-1-butanol
| 4276-09-9 |
|
Alpha-Fluorocinnamic Acid, 98%
| 350-90-3 |
|
Zinc chloride
| 7646-85-7 |
|
(Iodomethyl)trimethylsilane, 99%
| 4206-67-1 |
|
|